300 related articles for article (PubMed ID: 6088927)
1. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
Lee HR; Roeske WR; Yamamura HI
Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927
[TBL] [Abstract][Full Text] [Related]
2. Molecular approach to the calcium channel.
Glossmann H; Ferry DR; Goll A; Linn T
Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
[TBL] [Abstract][Full Text] [Related]
3. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
Ferry DR; Goll A; Glossmann H
Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
[TBL] [Abstract][Full Text] [Related]
4. Dihydropyridine [methyl-3H]PN 200-110 binding and myogenesis in intact muscle cells in vitro.
Navarro J
J Neurochem; 1986 Apr; 46(4):1166-9. PubMed ID: 3005507
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel receptor sites for (+)-[3H]PN 200-110 in coronary artery.
Yamada S; Kimura R; Harada Y; Nakayama K
J Pharmacol Exp Ther; 1990 Jan; 252(1):327-32. PubMed ID: 2153804
[TBL] [Abstract][Full Text] [Related]
6. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
[TBL] [Abstract][Full Text] [Related]
7. Protection by verapamil and nifedipine against ischaemia-induced loss of [3H]-(+)-PN 200-110 binding sites in the rat heart.
van Amsterdam FT; van Amsterdam-Magnoni MS; Haas M; Punt NC; Zaagsma J
Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):137-42. PubMed ID: 2156175
[TBL] [Abstract][Full Text] [Related]
8. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
Boles RG; Yamamura HI; Schoemaker H; Roeske WR
J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
[TBL] [Abstract][Full Text] [Related]
9. [3H]diltiazem binding to calcium channel antagonists recognition sites in rat cerebral cortex.
Schoemaker H; Langer SZ
Eur J Pharmacol; 1985 May; 111(2):273-7. PubMed ID: 2410283
[TBL] [Abstract][Full Text] [Related]
10. Potent enhancement of [3H]nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330A.
Lee HR; Jaros JA; Roeske WR; Wiech NL; Ursillo R; Yamamura HI
J Pharmacol Exp Ther; 1985 Jun; 233(3):611-6. PubMed ID: 3159884
[TBL] [Abstract][Full Text] [Related]
11. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.
Rasmussen RP; Minobe W; Bristow MR
Biochem Pharmacol; 1990 Feb; 39(4):691-6. PubMed ID: 2154992
[TBL] [Abstract][Full Text] [Related]
12. Effect of membrane depolarization on binding of [3H]nitrendipine to rat cardiac myocytes.
Green FJ; Farmer BB; Wiseman GL; Jose MJ; Watanabe AM
Circ Res; 1985 Apr; 56(4):576-85. PubMed ID: 2983904
[TBL] [Abstract][Full Text] [Related]
13. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
Wei XY; Rutledge A; Triggle DJ
Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
[TBL] [Abstract][Full Text] [Related]
14. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
Maan AC; Ptasienski J; Hosey MM
J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217
[TBL] [Abstract][Full Text] [Related]
15. The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats.
Ehlert FJ; Roeske WR; Itoga E; Yamamura HI
Life Sci; 1982 Jun; 30(25):2191-202. PubMed ID: 7109844
[TBL] [Abstract][Full Text] [Related]
16. Thermodynamic and kinetic aspects of agonist and antagonist binding to 1,4-dihydropyridine receptors.
Zheng W; Hawthorn M; Triggle DJ
Eur J Pharmacol; 1991 Oct; 208(2):137-47. PubMed ID: 1724760
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the properties of binding of calcium-channel activators and inhibitors to dihydropyridine receptors in chick heart membranes.
Maan AC; Hosey MM
Circ Res; 1987 Sep; 61(3):379-88. PubMed ID: 2441891
[TBL] [Abstract][Full Text] [Related]
18. Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
Garcia ML; King VF; Siegl PK; Reuben JP; Kaczorowski GJ
J Biol Chem; 1986 Jun; 261(18):8146-57. PubMed ID: 2424894
[TBL] [Abstract][Full Text] [Related]
19. Diltiazem-like effect of thioridazine on the dihydropyridine binding site of the calcium channel of rat myocardial membranes.
Thorgeirsson G; Rudolph SA
Biochem Biophys Res Commun; 1984 Jun; 121(2):657-63. PubMed ID: 6329206
[TBL] [Abstract][Full Text] [Related]
20. Dihydropyridine and peripheral type benzodiazepine binding sites: subcellular distribution and molecular size determination.
Doble A; Benavides J; Ferris O; Bertrand P; Menager J; Vaucher N; Burgevin MC; Uzan A; Gueremy C; Le Fur G
Eur J Pharmacol; 1985 Dec; 119(3):153-67. PubMed ID: 2419140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]